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Introduction  
astrocytomas are the most common group of primary 
brain tumors in the brain comprising 30–40% of all 
brain tumors.1 Glioblastoma multiforme constitute 
52% of primary brain tumors. The most prevalent age 
of glioblastoma is about 50-55 years and men are more 
prone to this brain tumor. Prognosis of glioblastoma is 
poor and the survival rate is 14.6 months after diagnosis.2 
Important risk factors for glioblastoma are high dose 
radiation, hereditary syndromes, and age increase.3
Glioblastoma is formed of a heterogenous tissue 
containing differentiated astrocytes and cancer stem cells.4 
The two properties of cancer stem cells are unlimited self-
renewal and multipotency. There are two stem cell niches 
in the adult mammalian brain including the dentate 
gyrus5 and the subventricular zone.6 Neural precursor 
cells seem to play an important role in the initiation and 
progression of different neurological diseases including 
Alzheimer’s disease, Parkinson’s disease, stroke, epilepsy, 
and schizophrenia.7 Also, theories were reported that 
neural precursor cells can be the origin of primary brain 
tumors.8 Specific gene alterations and diverse cellular 
differentiation can lead to primary brain tumors.5 
However, there is strong evidence that neural precursor 
cells are the origin of glial tumors.9 Two models have 
been suggested to clarify the initiation and progression 
of brain tumors including the stochastic model and the 
hierarchical model. The stochastic model explained that 
the tumor is formed of various or heterogeneous cells and 
all the cells are able to produce tumor. On the other hand, 
the hierarchical model refers to malignancies that are 
composed of cancer stem cells or initiating cells of tumor. 
Furthermore, cancer stem cells have the potential to 
produce tumors10 and through drug resistance and genetic 
disorders, they can lead to therapy failure in tumors.11 In 
this study, we focused on two cells types forming human 
glioblastoma and evaluated the morphology and antigen 
of differentiated astrocyte and cancer stem cells. 
Material and Methods
Isolation of Astrocyte From Human Glioblastoma Tissue
Glioblastoma tissue was confirmed by pathological 
assessment. Tissue was digested with 0.05% trypsin-
EDTA for 10 minutes at 37°C in a water bath. Tissue 
centrifugation was performed at 1000 rpm for 5 minutes, 
DMEM/F12 medium containing 1% (100 U/mL) 
antibiotic/antimycotic and 2% fetal bovine serum (FBS) 
was added to cells and then, incubated in 5% CO2 at 37°C 
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for 14 days. The medium containing FBS was changed 
every three days in the culture.
Isolation of Cancer Stem Cells From Human 
Glioblastoma Tissue 
The pieces of glioblastoma tissue were washed three times 
in calcium and magnesium free Hank’s balanced salt 
solution (HBSS) with 1 % penicillin and streptomycin. 
Then, the tissue was digested and incubated in trypsin for 
20 minutes. Digestion was stopped by trypsin inhibitor 
(80 μg/mL) in HBSS solution. Then, centrifugation was 
done at 1000 g for 5 minutes, at room temperature. The 
digested tissues were triturated in DMEM/F12 with 
a flamed polished Pasteur pipette and filtering was 
performed using a 70 μm strainer. The cell suspension was 
cultured in six well-plates with DMEM/F12 containing 20 
ng/mL, epidermal growth factor (EGF), 20 ng/mL, basic 
fibroblast growth factor (bFGF), 1% glutamax 1% B27, 
1% penicillin–streptomycin. The cells were incubated 
at 5% CO2, 37°C. The medium in the supplements was 
changed every 2-3 days.
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde in 0.2M 
phosphate-buffered saline (PBS) for 20 minutes, and 
then washed with PBS three times. Then, cells were 
permeabilized in 0.2% Triton X-100 in PBS for 5 minutes 
at room temperature. Then, cells were blocked in 10% 
albumin bovine serum for 1 hour at room temperature and 
incubated with primary antibodies of rabbit anti-nestin 
(1:250; Abcam), rabbit anti-SOX2 (1:500; Abcam), and 
rabbit anti-GFAP (1:300, Abcam) overnight at 4°C. After 
being washed with PBS, the cells were incubated with 
secondary antibody of 1:200 fluorescein isothiocyanate 
(FITC)-conjugated goat anti-rabbit (Abcam, USA) for 2 
hours at room temperature. Finally, protein expression 
in the cells were observed using an inverted fluorescence 
microscopy.
Statistical Analysis
All tests were repeated in the three independent 
experiments. The data were qualitative and were reported 
as images.
Results
Astrocytes Morphology of Human Glioblastoma 
Multiforme
Astrocytes were derived from human glioblastoma 
tissue (Figure 1A). Results indicated that there were 
two morphology types in cell culture. 1) Epithelioid 
morphology was observed to be large, abundance 
cytoplasm and interconnecting processes (Figure 1B). 
2) Fibroblastic morphology was slender, elongated, and 
spindle-shaped (Figure 1C). The immunocytochemistry 
test indicated the expression of GFAP protein in the cells, 
confirming the presence of the astrocyte in the culture 
medium (Figure 1D).
Isolation and Culture of Adult Human Glioblastoma 
Cancer Stem Cells 
Cancer stem cells were isolated and cultured from human 
adult glioblastoma tissue. The floating single cells started 
to grow, divide and form small clusters for 6-8 weeks. 
Neurosphere morphology was observed to be round and 
floating in the culture medium (Figure 2). 
 
Antigen Evaluation of Cancer Stem Cells of Human 
Glioblastoma
The cancer stem cells of glioblastoma were assessed using 
immunochemistry test for expression of the nestin and 
SOX2 antigens. Immunocytochemical staining indicated 
that nestin and SOX2 antigens were positively expressed 
Figure 1. Morphology of the Astrocyte Types. (A) tissue of the 
human glioblastoma. (B) Astrocytes with epithelioid morphology, 
scale bar: 100 μm. (C) Astrocytes with fibroblastic morphology, 
scale bar: 100 μm. (D) Confirmation of cultured astrocytes 
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in primary neurospheres (Figure 3).
Discussion
In our study, we separated cancer stem cells and astrocyte 
from glioblastoma tissue, and found that the isolated cells 
have a morphology similar to cancer stem cells: sphere-like 
form, self-renewal, potential of differentiation. We further 
evaluated the other properties of cancer stem cells on our 
isolated cells. Nestin and SOX2 were selected to assess the 
property of cancer stem cells. Many studies select nestin 
as a marker to evaluate the features of brain cancer stem 
cells.12 New results also reported that nestin was over-
expressed in glioblastoma stem cells.13 In our study, the 
isolated cells were nestin positive, indicating cancer stem 
cells. We cultured the cancer stem cells in the medium 
similar to neural stem cells and noticed this method 
could lead to growth of the cancer stem cells. Astrocytes 
are a differentiated cell in the glioblastoma. This cell is 
generally located in the periphery part of glioblastoma. 
It seems that astrocytes of glioblastoma are differentiated 
from glioblastoma stem cells.9 Astrocytes were GFAP 
positive. GFAP is a specific marker of astrocyte.14
Cancer stem cells play different roles in glioblastoma 
including the ability to proliferate and differentiate, tropism 
and migration potential to other regions, resistance to 
drugs and toxins, and resistance to apoptosis.15 Studies 
were reported that cancer stem cells are dangerous and 
lead to poor diagnosis, therapy resistance and increase of 
morbidity and mortality in patients with glioblastoma.16 
Information about cancer stem cells features could be 
helpful in how glioblastoma is formed and involved in 
tumorigenesis. Also, we can assess cellular and molecular 
mechanism of cancer stem cell tumorigenesis in order 
to find the suitable therapy approach. Unfortunately, it 
remains ambiguous whether cancer stem cells are derived 
from the transformation of normal neural stem cells 
or whether the differentiation of a mature brain cell is 
responsible.17 These theories may lead to new pathways 
to introduce therapeutic and pharmacological approaches 
for glioblastoma.  
Conclusion 
In this study, we successfully isolated and cultured 
astrocyte and cancer stem cells from glioblastoma 
tissue. Furthermore, we reported the features and 
morphology of cancer stem cells and astrocytes in the 
human glioblastoma tissue. However, glioblastoma is a 
heterogenous and complex brain tumor.
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